MeSH D006961 - hyperparathyroidism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Calcitriol | Calcitriol |  | 2001-10-12 |  |  |
| Paricalcitol | Paricalcitol |  | 2013-09-27 |  |  | |
| Lupin Research | Doxercalciferol | Doxercalciferol |  | 2018-11-01 |  |  |
| Sandoz | Doxercalciferol | Doxercalciferol |  | 2014-05-05 |  |  |
| Paricalcitol | Paricalcitol |  | 2011-07-27 |  |  | |
| AbbVie | Calcitriol | Calcijex |  | 1986-09-25 |  |  |
| Paricalcitol | Zemplar |  | 1998-04-17 | $379 M | Q3/12-Q3/13 | |
| Sanofi | Doxercalciferol | Hectorol |  | 1999-06-09 |  |  |
| Aurobindo Pharma | Paricalcitol | Paricalcitol |  | 2016-01-14 |  |  |
| Dr Reddys Laboratories | Paricalcitol | Paricalcitol |  | 2014-06-24 |  |  |
| Rising Pharmaceuticals | Doxercalciferol | Doxercalciferol |  | 2016-09-09 |  |  |
| Paricalcitol | Paricalcitol |  | 2014-06-24 |  |  | |
| Calcitriol | Calcitriol |  | 2018-11-21 |  |  | |
| Sun Pharmaceutical Industries | Calcitriol | Calcitriol |  | 2019-02-21 |  |  |
| Doxercalciferol | Doxercalciferol |  | 2019-11-14 |  |  | |
| Marksans Pharma | Paricalcitol | Paricalcitol |  | 2016-10-07 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
80%4/5
Phase 2
0%0/4
Phase 3
86%6/7
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use